All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
With unrivaled expertise and experience in antibody discovery and development, Creative Biolabs has developed an advanced platform to develop the CAR specific monoclonal antibodies. The CAR-specific antibody will help to detect the CAR expression during CAR in vitro assays. Our scientists are dedicated to comprehensive services for our one-stop CAR-T cell development.
Immunotherapies have achieved unparalleled success in recent years, especially the chimeric antigen receptor (CAR) T therapy. According to the data in ClinicalTrial.gov, more than 600 CAR-T cell therapy programs are under clinical trials. During CAR-T cell therapy discovery, CAR detection is needed in the following stages.
For CAR engineered T cells or other cell types, CAR expression needs to be confirmed.
After CAR-T cell infusion in animal models, bio-distribution of CAR-T cell needs to be tested.
Since CAR-positive T cell is related to anti-tumor activity, CAR expression and percentage of CAR-positive T cells after CAR-T cell infusion are critical.
To facilitate CAR detection in all stages during CAR-T cell therapy discovery and development, Creative Biolabs has developed a specialized team to develop CAR-specific anti-idiotypic monoclonal antibodies. We are committed to developing anti-CAR mAbs with high sensitivity and high specificity. All anti-CAR mAbs will be validated before delivery to ensure high performance. Here are some featured CARs under frequent investigation. Our services cover the following CARs, but not limited to these. If you have any specific requirements, please just reach out to our team for an exclusive conversation.
For Hematologic Tumors | ||||
Anti-CD19 CARs | Anti-CD20 CARs | Anti-CD22 CARs | Anti-CD23 CARs | Anti-CD30 CARs |
Anti-CD33 CARs | Anti-CD38 CARs | Anti-CD70 CARs | Anti-CD123 CARs | Anti-CD44v6 CARs |
Anti-BCMA CARs | Anti-CD138 CARs | Anti-ROR CARs | Anti-NY-ESO-1 CARs | Anti-FAP CARs |
Anti-NKG2D CARs | Anti-FLT3 CARs | Anti-CLL1 CARs | Anti-Lewis Y CARs | etc. |
For Solid Tumors | ||||
Anti-CEA CARs | Anti-CD133 CARs | Anti-c-Met CARs | Anti-EGFR CARs | Anti-EPCAM CARs |
Anti-GD2 CARs | Anti-FRα CARs | Anti-GPC3 CARs | Anti-GUCY2C CARs | Anti-HER2 CARs |
Anti-ICAM-1 CARs | Anti-IL13Rα2 CARs | Anti-IL11Rα CARs | Anti-KRAS CARs | Anti-MAGE CARs |
Anti-MUC1 CARs | Anti-PSCA CARs | Anti-CSPG CARs | Anti-IL-13R CARs | Anti-MSLN CARs |
Anti-VEGFR CARs | Anti-PSMA CARs | Anti-WT1 CARs | Anti-CD24 CARs | etc. |
We can offer CAR-specific antibody development services for various kinds of CARs, please reach out to us for further communication. |
With our skilled and advanced antibody development platforms, Creative Biolabs is confident to be the best option for our clients. If you need monoclonal antibody to detect the CAR, let's get the conversation started for your requests. Please feel free to contact us and our scientists will offer the best assistance at the earliest convenience.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION